AaiPharma Receives Grand Jury Subpoena
- Share via
From Reuters
Drug maker AaiPharma Inc. said that it had received subpoenas from a federal grand jury for testimony and a variety of documents and that it had been notified that it might soon receive a subpoena from the Securities and Exchange Commission.
The company has said it is investigating “sales abnormalities” involving its asthma drug and painkillers. Its chief executive has resigned, and it has received a Nasdaq delisting notice.
AaiPharma said it would cooperate with the investigations.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
